LBA62 Preoperative modified FOLFIRINOX (mFOLFIRINOX) with or without chemoradiation (CRT) in borderline resectable pancreatic cancer (BRPC): Results from the randomized phase II trial PANDAS/PRODIGE 44
A. Lambert, Olivier Bouché, Ahmet Ayav, J-B. Bachet, Lilian Schwarz, G. Piessen, V. Vendrely, Valérie Laurent, Emilie Thibaudeau, Laurent Miglianico, Yves Rinaldi, P. Hammel, T. Conroy
Topics & Concepts
MedicineFOLFIRINOXPancreatic cancerOncologyInternal medicineCancerColorectal cancerOxaliplatinPancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsHepatocellular Carcinoma Treatment and Prognosis